Egyptian International Pharmaceutical Industries Company SAE

EIPICO maintains a debt-to-equity ratio of 1.41, indicating a moderate reliance on debt financing, while its liquidity position is characterized as medium, with a current ratio of 1.16. The company’s free cash flow is negative at -366.6 million EGP, and its operating cash flow is 1.1 billion EGP, suggesting that capital expenditures are outpacing cash generation. Profitability metrics show a return on equity (ROE) of 23.49% and a return on assets (ROA) of 8.03%, both exceeding the typical thresholds for the pharmaceutical industry. The company’s operating income of 1.03 billion EGP and net income of 1.47 billion EGP reflect strong earnings performance relative to its revenue of 9.44 billion EGP. EIPICO’s revenue is primarily concentrated in its domestic and regional export markets, with disclosed exports to Arab, African, Asian, and Eastern European countries. The company does not provide segment-specific revenue breakdowns, but its product portfolio includes anesthetics, analgesics, antibiotics, and vitamins, indicating a diversified therapeutic focus. Looking ahead, EIPICO is projected to maintain a stable growth trajectory, with no significant revenue decline or expansion indicated in the outlook. The company’s capital expenditures of -1.35 billion EGP suggest ongoing investment in production capabilities, which may support long-term growth. The company faces a medium liquidity risk due to its negative net cash position after subtracting total debt. While dilution risk is currently low, the company’s long-term debt of 8.81 billion EGP and total liabilities of 12.03 billion EGP represent a notable leverage burden. No recent dilutive events have been disclosed, and the company’s shares outstanding remain unchanged between basic and diluted counts. Recent filings and transcripts do not indicate any material events or earnings surprises. Analysts have assigned a mean price target of 96.80 EGP and a median of 95.80 EGP, with a mean recommendation of 1.33, indicating a generally positive outlook from the investment community.